Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose corticosteroids plus Myfortic versus full-dose corticosteroids for initial treatment of adult minimal change nephrotic syndrome
2009-011170-15Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mycophenolate sodium and corticosteroids in nephrosis (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Complete remission rate at 4 weeks. Started May 2009; status: completed.
02
Drugs
mycophenolate sodiumcorticosteroids
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2009-011170-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011170-15.